Turnaround Time: Within 1 day
CPT Code:


Test Type: 1 mL Serum (preferred) or plasma
Stability Time:



Room temperature

14 days


14 days


14 days

Freeze/thaw cycles

Stable x3


Magnesium deficiency produces neuromuscular disorders. It may cause weakness, tremors, tetany, and convulsions. Hypomagnesemia is associated with hypocalcemia, hypokalemia, long-term hyperalimentation, intravenous therapy, diabetes mellitus, especially during treatment of ketoacidosis; alcoholism and other types of malnutrition; malabsorption; hyperparathyroidism; dialysis; pregnancy; and hyperaldosteronism. Renal loss of magnesium occurs with cis-platinum therapy. Alfrey also adds amphotericin toxicity to the causes of hypomagnesemia.

Magnesium deficiency is described with cardiac arrhythmias. The concept that magnesium deficiency may cause arrhythmias is repeatedly expressed.

Increased magnesium levels relate mostly to patients in renal failure. Marked increases may be found in such patients who take magnesium salts (eg, as antacids which contain magnesium). Increased serum magnesium is also found with Addison disease and in pregnant patients with severe preëclampsia or eclampsia who are receiving magnesium sulfate as an anticonvulsant. Hypermagnesemia may occur in patients using magnesium-containing cathartics.1 High magnesium levels are manifested by decreased reflexes, somnolence, and heart block.2

Indications for measurement of serum magnesium include the presence of unexplained hypocalcemia, instances in which hypokalemia is unresponsive to potassium supplementation, and in patients who have cardiac disorders in which hypomagnesemia may be especially hazardous such as congestive failure, ventricular ectopy, digitalis use, or left ventricular hypertrophy. Serum magnesium is indicated only selectively in patients on diuretics: those on high dose thiazides, loop diuretics or hydrochlorothiazide in doses >50 mg/day.3

Because an association between aminoglycoside therapy and severe hypomagnesemia is described, a recommendation is published to measure serum magnesium in subjects receiving aminoglycosides. Recommendations also exist to measure it in patients on cyclosporine.4,5

Hemolysis will yield elevated results as levels in erythrocytes are two to three times higher than serum. Bilirubin may cause falsely low values.6

Parathormone enhances tubular reabsorption of magnesium. Measure magnesium in patients with hypocalcemia, of whom 23%, without renal failure, were found in one study to have hypomagnesemia.2 Magnesium containing drugs can cause toxic levels in patients with impaired renal function. A causal relation between decreased Mg2+ content of cardiac muscle/coronary arteries and nonocclusive sudden-death ischemic heart disease has been proposed. Serum magnesium constitutes only a small fraction of total body stores and may not predict magnesium status correctly.7 Magnesium acts as a metallic cofactor in over 300 enzymatic reactions.8 A positive correlation between normomagnesemia and successful resuscitation is reported.9 Serum magnesium has prognostic importance in congestive heart failure.10

1. Gerard SK, Hernández C, Khayam-Bashi H. Extreme hypermagnesemia caused by an overdose of magnesium-containing cathartics. Ann Emerg Med. 1988 Jul; 17(7):728-731. PubMed 3382076

2. Wong ET, Rude RK, Singer FR, Shaw ST Jr. A high prevalence of hypomagnesemia and hypermagnesemia in hospitalized patients. Am J Clin Pathol. 1983 Mar; 79(3):348-352. PubMed 6829504

3. Kroenke K, Wood DR, Hanley JF. The value of serum magnesium determination in hypertensive patients receiving diuretics. Arch Intern Med. 1987 Sep; 147(9):1553-1556. PubMed 3632162

4. Chernow B, Bamberger S, Stoiko M, et al. Hypomagnesemia in patients in postoperative intensive care. Chest. 1989 Feb; 95(2):391-397. PubMed 2914492

5. Barton CH, Vaziri ND, Martin DC, Choi S, Alikhani S. Hypomagnesemia and renal magnesium wasting in renal transplant recipients receiving cyclosporine. Am J Med. 1987 Oct; 83(4):693-699. PubMed 3314493

6. McCoy S, Maclaren NK, Gudat JC. Bilirubin interferes in the aca determination of Mg2+ in serum. Clin Chem. 1983 Jun; 29(6):1309. PubMed 6851111

7. Elin RJ. Assessment of magnesium status. Clin Chem. 1987 Nov; 33(11):1965-1970. PubMed 3315301

8. Reinhart RA. Clinical correlates of the molecular and cellular actions of magnesium on the cardiovascular system. Am Heart J. 1991 May; 121(5):1513-1521. PubMed 2017983

9. Cannon LA, Heiselman DE, Dougherty JM, Jones J. Magnesium levels in cardiac arrest victims: relationship between magnesium levels and successful resuscitation. Ann Emerg Med. 1987 Nov; 16(11):1195-1199. PubMed 3310763

10. Gottlieb SS, Baruch L, Kukin ML, Bernstein JL, Fisher ML, Packer M. Prognostic importance of the serum magnesium concentration in patients with congestive heart failure. J Am Coll Cardiol. 1990 Oct; 16(4):827-831. PubMed 2212365

Collection Details:

Collection Instructions:

Red-top tube, gel-barrier tube, or green-top (lithium heparin) tube. Do NOT use Oxalate, EDTA, or Citrate Plasma.

Separate serum or plasma from cells within 45 minutes of collection.

Maintain specimen at room temperature.